153 related articles for article (PubMed ID: 32636160)
1. Natural History of Renal Angiomyolipoma Favors Surveillance as an Initial Approach.
Nason GJ; Morris J; Bhatt JR; Richard PO; Martin L; Ajib K; Tan GH; Jewett MAS; Jhaveri K; Zlotta AR; Lee JY; Perlis N; Hamilton RJ; Finelli A
Eur Urol Focus; 2021 May; 7(3):582-588. PubMed ID: 32636160
[TBL] [Abstract][Full Text] [Related]
2. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy.
Bhatt JR; Richard PO; Kim NS; Finelli A; Manickavachagam K; Legere L; Evans A; Pei Y; Sykes J; Jhaveri K; Jewett MAS
Eur Urol; 2016 Jul; 70(1):85-90. PubMed ID: 26873836
[TBL] [Abstract][Full Text] [Related]
3. Renal angiomyolipoma: long-term results after arterial embolization.
Kothary N; Soulen MC; Clark TW; Wein AJ; Shlansky-Goldberg RD; Crino PB; Stavropoulos SW
J Vasc Interv Radiol; 2005 Jan; 16(1):45-50. PubMed ID: 15640409
[TBL] [Abstract][Full Text] [Related]
4. Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.
Hatano T; Egawa S
Asian J Surg; 2020 Oct; 43(10):967-972. PubMed ID: 31959574
[TBL] [Abstract][Full Text] [Related]
5. Clinical behavior and management of three types of renal angiomyolipomas.
Lee KH; Tsai HY; Kao YT; Lin HC; Chou YC; Su SH; Chuang CK
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):162-169. PubMed ID: 29549981
[TBL] [Abstract][Full Text] [Related]
6. The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma.
Chan CK; Yu S; Yip S; Lee P
Urology; 2011 Mar; 77(3):642-8. PubMed ID: 21131030
[TBL] [Abstract][Full Text] [Related]
7. The impact of renal angiomyolipoma on estimated glomerular filtration rate in patients with tuberous sclerosis complex.
Seyam R; Khudair WA; Kattan SA; Al Otaibi MF; Skaff F; AlTaweel WM
Ann Saudi Med; 2016; 36(5):356-363. PubMed ID: 27710989
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic selective arterial embolization for renal angiomyolipomas: efficacy and evaluation of predictive factors of significant shrinkage.
Lin L; Wang C; Pei R; Guan H; Wang J; Yang M; Tong X; Zou Y
Int Urol Nephrol; 2018 Oct; 50(10):1765-1770. PubMed ID: 30101376
[TBL] [Abstract][Full Text] [Related]
9. Renal angiomyolipoma: optimal treatment based on size and symptoms.
Dickinson M; Ruckle H; Beaghler M; Hadley HR
Clin Nephrol; 1998 May; 49(5):281-6. PubMed ID: 9617489
[TBL] [Abstract][Full Text] [Related]
10. Conservative treatment of renal angiomyolipomas in patients with tuberous sclerosis.
Hadley DA; Bryant LJ; Ruckle HC
Clin Nephrol; 2006 Jan; 65(1):22-7. PubMed ID: 16429838
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic cryoablation of angiomyolipomas in adolescents and young adults: A report of four cases associated with tuberous sclerosis and 1 case of sporadic origin.
Trelborg K; Nielsen TK; Østraat EØ; Olsen LH
J Pediatr Urol; 2016 Dec; 12(6):384.e1-384.e6. PubMed ID: 27346068
[TBL] [Abstract][Full Text] [Related]
12. Conservative management of giant symptomatic angiomyolipomas in patients with the tuberous sclerosis complex.
Danforth TL; Lane BR; Novick AC
BJU Int; 2007 Oct; 100(4):794-7. PubMed ID: 17590180
[TBL] [Abstract][Full Text] [Related]
13. Sporadic versus Tuberous Sclerosis Complex-Associated Angiomyolipomas: Predictors for Long-Term Outcomes following Transcatheter Embolization.
Sheth RA; Feldman AS; Paul E; Thiele EA; Walker TG
J Vasc Interv Radiol; 2016 Oct; 27(10):1542-9. PubMed ID: 27522275
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center.
Ruud Bosch JLH; Vekeman F; Duh MS; Neary M; Magestro M; Fortier J; Karner P; Ionescu-Ittu R; Zonnenberg BA
Int Urol Nephrol; 2018 Mar; 50(3):459-467. PubMed ID: 29333579
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention.
Ouzaid I; Autorino R; Fatica R; Herts BR; McLennan G; Remer EM; Haber GP
BJU Int; 2014 Sep; 114(3):412-7. PubMed ID: 24325283
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR inhibition.
Krummel T; Garnon J; Lang H; Gangi A; Hannedouche T
BMC Urol; 2014 Sep; 14():77. PubMed ID: 25258166
[TBL] [Abstract][Full Text] [Related]
17. What Are the Indications for Prophylactic Embolization of Renal Angiomyolipomas? A Review of the Current Evidence in the Literature.
Ryan JW; Farrelly C; Geoghegan T
Can Assoc Radiol J; 2018 Aug; 69(3):236-239. PubMed ID: 29804911
[TBL] [Abstract][Full Text] [Related]
18. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated.
Sooriakumaran P; Gibbs P; Coughlin G; Attard V; Elmslie F; Kingswood C; Taylor J; Corbishley C; Patel U; Anderson C
BJU Int; 2010 Jan; 105(1):101-6. PubMed ID: 19493268
[TBL] [Abstract][Full Text] [Related]
19. Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.
Fernández-Pello S; Hora M; Kuusk T; Tahbaz R; Dabestani S; Abu-Ghanem Y; Albiges L; Giles RH; Hofmann F; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Volpe A; Ljungberg B; Bex A; Bensalah K
Eur Urol Oncol; 2020 Feb; 3(1):57-72. PubMed ID: 31171501
[TBL] [Abstract][Full Text] [Related]
20. Can we predict the existence of extrarenal feeders to renal angiomyolipomas?
Zhang X; Kuwatsuru R; Toei H; Yashiro D; Okada S; Kato H
Eur Radiol; 2019 May; 29(5):2499-2506. PubMed ID: 30542748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
